Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
long intergenic non-protein coding RNA 1351 (LINC01351)
- Target
- LINC01351
- Molecular classification
- long non-coding RNA (lncRNA), non-protein coding RNA, other
01
Overview
BRINP3 divergent transcript (BRINP3-DT), also known as LINC01351 (long intergenic non-protein coding RNA 1351), is a long non-coding RNA gene located near or transcribed divergently from the BRINP3 locus. As a lincRNA, BRINP3-DT/LINC01351 does *not* encode a protein and is believed to function as a regulatory RNA, but there are currently no well-established biological functions, disease roles, drug interactions, or known safety/therapeutic concerns associated with it. Most published data and disease associations pertain to the protein-coding gene BRINP3, not the divergent non-coding transcript[1][2][3][4][5]. The BRINP3 divergent transcript remains poorly characterized in current biomedical databases and literature.
- Other names
- BRINP3 divergent transcriptBRINP3-DTLINC01351long intergenic non-protein coding RNA 1351
02
Biological functions
unknownlikely involved in transcriptional regulation or chromatin structure (based on classification as a long intergenic non-coding RNA, but no direct evidence found)
03
Disease associations
unknown (no direct evidence for disease involvement for the divergent transcript/lincRNA form found; the canonical BRINP3 protein-coding gene is linked to cancer, cardiovascular, and inflammation, but no such link is found for BRINP3-DT/LINC01351)
Beyond the preview
Go deeper on long intergenic non-protein coding RNA 1351 (LINC01351).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on long intergenic non-protein coding RNA 1351 (LINC01351).